Streetbeat News

Analyst Ratings

ARQT

Mizuho analyst Uy Ear has downgraded Arcutis Biotherapeutics (NASDAQ:ARQT) from Buy to Neutral and lowered the price target from $57 to $4.

Portfolio Pulse from Benzinga Newsdesk

October 26, 2023 | 6:43 pm

VRT

Mizuho analyst Brett Linzey maintains a Neutral rating on Vertiv Hldgs (NYSE:VRT) and raises the price target from $32 to $39.

Portfolio Pulse from Benzinga Newsdesk

October 26, 2023 | 6:35 pm

ROP

Mizuho analyst Brett Linzey maintains a Neutral rating on Roper Techs (NASDAQ:ROP) and raises the price target from $475 to $485.

Portfolio Pulse from Benzinga Newsdesk

October 26, 2023 | 6:33 pm

FTV

Mizuho analyst Brett Linzey maintains a Neutral rating on Fortive (NYSE:FTV) and lowers the price target from $70 to $66.

Portfolio Pulse from Benzinga Newsdesk

October 26, 2023 | 6:31 pm

AVGO

Broadcom's (NYSE:AVGO) short percent of float has risen 6.49% since its last report, with 6.34 million shares sold short, which is 1.97% of all regular shares available for trading. This increase in short interest can act as an indicator of market sentiment towards a particular stock. However, compared to its peers, Broadcom has less short interest as a percentage of float (3.63%).

Portfolio Pulse from Benzinga Insights

October 26, 2023 | 6:30 pm

VMC

Vulcan Materials's (NYSE:VMC) short percent of float has fallen 3.57% since its last report, with 1.59 million shares sold short, which is 1.35% of all regular shares available for trading. It would take traders 2.21 days to cover their short positions on average. The company has less short interest than most of its peers, with an average of 1.69%.

Portfolio Pulse from Benzinga Insights

October 26, 2023 | 6:30 pm

QCOM

Qualcomm's (NYSE:QCOM) short percent of float has risen 21.43% since its last report, with 13.24 million shares sold short, which is 1.19% of all regular shares available for trading. It would take traders 1.28 days to cover their short positions on average. The company's short interest is less than its peer group average of 3.67%.

Portfolio Pulse from Benzinga Insights

October 26, 2023 | 6:30 pm

EW

Mizuho analyst Anthony Petrone has maintained a 'Buy' rating on Edwards Lifesciences (NYSE:EW) but lowered the price target from $90 to $85.

Portfolio Pulse from Benzinga Newsdesk

October 26, 2023 | 6:29 pm

ALKS

Mizuho analyst Uy Ear maintains a Buy rating on Alkermes (NASDAQ:ALKS) but lowers the price target from $37 to $35.

Portfolio Pulse from Benzinga Newsdesk

October 26, 2023 | 6:28 pm

SLGN

Truist Securities analyst Michael Roxland maintains a 'Buy' rating on Silgan Holdings (NYSE:SLGN) but has lowered the price target from $56 to $52.

Portfolio Pulse from Benzinga Newsdesk

October 26, 2023 | 6:24 pm